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patients aged ≥ 70 years. On multivariate analysis for cOS, no 
advantage for PMRT was detected (HR: 1.084; 95% CI:0.986-
1.191, p=0.095). Variables favouring the use of postoperative 
radiotherapy on multivariate logistic regression analysis 
included young age (p<0.001), large tumour size (pT3/4) 
(p<0.001), positive resection margin (p<0.001), and positive 
nodal status (p<0.001). High-risk patients with ≥ 4 positive 
lymph nodes who underwent mastectomy in 1998-2012 had a 
significant increased likelihood of receiving PMRT (OR 6.245) 
as compared to patients treated in the early period of 
analysis, from 1988-1997 (OR 2.837). 
 
Conclusion: The present study was useful in providing a 
window on the adoption of PMRT in a large population-based 
cohort, and to determine trends over time, as well as to 
characterize and quantify the outcome in clinical practice. A 
significant shift in indications for PMRT was registered, 
especially for high-risk patients with ≥ 4 positive lymph 
nodes. Moreover, the present findings track a substantial 
variation and apparent underuse of PMRT within the 
vulnerable population of elderly patients aged ≥ 80 years.  
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Purpose or Objective: Phase III randomised controlled trials 
and subsequent evidence-based treatment guidelines suggest 
that breast hypofractionation has low toxicity and similar 
cancer outcomes compared to patients undergoing standard 
fractionation. However, uptake of hypofractionation has not 
been universal. The aim of this study was to investigate the 
uptake of hypofractionation regimens in all public radiation 
oncology facilities in NSW.  
 
Material and Methods: Data from the NSW Clinical Cancer 
Registry were extracted, cleaned and verified. The inclusion 
criteria included those patients that are node negative breast 
cancer (TNM stage I or IIA), year of diagnosis between 2007 to 
2012, year of treatment between 2008 and 2012 and received 
external beam radiotherapy in a public radiotherapy facility. 
Data extracted included dose and fractionation type, patient 
age at first fraction, distance from treatment facility, year of 
diagnosis, year of treatment, laterality of treatment and 
department of treatment. In this analysis, standard 
fractionation was defined as dose per fraction of between 1.8 
– 2.4 Gy per fraction and hypofractionation as above 2.4 Gy 
per fraction. Univariate and multivariate analyses were 
performed to assess which factors predict for 
hypofractionation use.  
 
Results: Of the 6066 early breast cancer patients fulfilling 
the study criteria, 3947 patients (65%) had standard 
fractionation and 2119 patients (35%) received 
hypofractionation in 14 public radiotherapy centres in NSW. 
There was a wide spread of fractionation used across 
departments ranging from 6% to 92%. Hypofractionation use 
exceeded 50% in only 4 departments. Statistically significant 
factors to predict for hypofractionation use were increasing 
patient age, right sided breast cancer, further distance from 
home to the treating facility, more recent treatment, facility 
and clinician treating.  
 
Conclusion: While hypofractionation has become more 
common across NSW, there remains a substantial proportion 
of patients for whom hypofractionation would be considered 
appropriate who are not receiving hypofractionation. This has 
also been found to be the case in US studies, although we 
believe we are the first to identify laterality as an indicator. 
Understanding factors that may predict standard 
fractionation use might assist in developing strategies to 
address the issue. Hypofractionation for early breast cancer 
being adopted more widely would lead to greater patient 
convenience, better resource efficiencies in radiation 
oncology departments and perhaps even increase the use of 
post-lumpectomy radiotherapy, as some patients might 
currently forego radiotherapy due to the perceived 
inconvenience of standardly fractionated radiotherapy. 
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Purpose or Objective: To investigate inter-operator and 
inter-center variability in lymph node (LN) volume 
delineations in breast cancer (BC) nodal irradiation. 
 
Material and Methods: The study was conducted by the 
Italian Society of Radiation Oncologists (AIRO) - Breast Cancer 
Working Group. For each center, 3 radiation oncologists (ROs) 
with different expertise were involved: 1 junior (J), 1 senior 
(S) not dedicated to BC, and 1 senior (E) expert in BC. The CT 
series of 3 patients at different levels of complexity were 
selected: 1 with simple anatomy (P1), 1 obese (P2) and 1 
with impaired arm mobility (P3). ROs were asked to contour 
axillary nodes, as follows: I level (L1), II level (L2) and III 
level, the latter was further divided into infra (L3) and 
supraclavicular (L4) nodes on CT images by applying 
guidelines on breast contouring released by AIRO. The inter-
category and the inter-center variability were investigated, 
by evaluating the variability in volume size, structure overlap 
(measured as Dice similarity coefficient, DSC), and average 
Hausdorff distance (AHD) between contours. 
 
Results: Thirty-nine ROs from 14 centres participated and 
468 contours were obtained. Firstly, the analysis was focused 
on volume size. By comparing the operators, E-ROs contoured 
slightly larger volumes than S-ROs and J-ROs, with no 
statistically significant differences. Conversely, statistically 
significant differences were found in volume size when 
stratifying for patients (larger volumes were obtained for P2) 
and for LN levels (in order of size: L1, L4, L2, L3 – L1 being 
the largest and L3 the smallest). Secondly, descriptive and 
statistical intra-group analysis showed that all the 3 principal 
factors (different expertise, LN level and patient) 
contributed to inter-operator variability. When analysing 
DSC, poor agreement was found among ROs stratified for 
expertise (Fig. 1a) and the differences between S-ROs and 
the other groups were statistically significant. Considering 
the LN levels (Fig. 1b), the highest concordance was found in 
the contouring of L1 and L4 levels and the lowest for L3 
(p<0.05). Moreover, inter-operator consistency dramatically 
decreased as patient complexity increased (Fig. 1c). 
Consistent results were found in the analysis of AHD. Finally, 
considering the inter-center variability, statistically 
significant differences were found in 38.5% of comparisons 
when considering intra-center median DSC (Fig. 1d) and in 
33% of comparisons when considering intra-center median 
AHD.  
 






Conclusion: Guidelines for regional LN did not significantly 
improve the consistency of contouring among ROs. The J-ROs 
were the most accurate in contouring according to AIRO 
guidelines and showed the highest level of homogeneity, 
while the S-ROs followed the guidelines to a lesser extent, 
probably because of higher self-confidence. 
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Purpose or Objective: Optimal local treatment for young 
women with early-stage breast cancer remains controversial 
because of the lack of knowledge as to whether local 
recurrence (LR) can be the site of metastatic disease. The 
aim was to describe the age depending LR pattern as a 
function of time (0-20 years) and local treatment, given as 
either Breast conserving therapy (BCT) or mastectomy alone. 
Furthermore to test, if LR was associated with an excess risk 
of distant metastasis (DM) and translate into a higher 
mortality after BCT. 
 
Material and Methods: 1077 Danish patients were enrolled in 
this population-based cohort study. The patients were 
diagnosed in the period from 1989 to 1998, classified as low-
risk (lymph-node negative, tumor size <5 cm), treated with 
mastectomy (N= 712) or BCT (N=364) and received no 
systemic treatment. The cohort included all Danish low-risk 
patients below 41 years (N = 305) and patients from one part 
of Denmark. Patient identification, treatment, and 20-year 
recurrence data were ascertained from the DBCG. 
 
 
Results: After 20 years the cum incidence of LR was 18 % 
after BCT (N=66) and 6.7% after mastectomy (N=55). The LR 
pattern of failure was different depending on age: young ( ≤45 
year) vs. old (<45 year) and treatment: BCT vs. mastectomy. 
The older mastectomy patients developed only very early LR 
(< 5 year), young mastectomy patients developed early LR (0-
10 year), and BCTpatients despite age developed LR 
throughout the 20-year period (Fig 1). Among young patients, 
the BCT group had a higher risk of LR after 20 years 
compared to the mastectomy, RD = 13% (4.8-20), and LR was 
a prognostic marker for DM, HR =2.0 (1.3-3.1). The 20-year 
mortality among the young patients was significantly higher 
after BCT compared to mastectomy: Breast cancer death, HR 
=1.6 (1.0-2.5) and Death, HR =1.7 (1.1-2.6). Among the older 
patients, LR was not a prognostic marker for DM after 20 
years, HR: 0.9 (0.3-2.2), and local treatment was not 
associated with Breast cancer death, HR =0.8 (0.5-1.2). 
 
 
Conclusion: In the group of patients treated with 
mastectomy all LR occured within the first 10 years. In 
contrast, BCT patients developed LR throughout the period 
and had a significantly higher cumulative incidence of LR at 
20 years. Within the young patients LR was associated with 
DM, and BCT was associated with a significantly higher 
mortality. Among older patients LR was not a prognostic 
marker for DM and there was no difference in Breast cancer 
mortality between the two treatment groups. 
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Purpose or Objective: To report an analysis of treatment 
outcomes and toxicity of a cohort of patients re- irradiated 
after a second breast conserving surgery or no further 
surgery. 
 
Material and Methods: Between 11/05 and 10/15, 32 women 
were re- irradiated with 50- 60 Gy for locally recurrent breast 
cancer. The first RT course included postoperative 
radiotherapy with a total dose of 50 Gy in 25 or 50,4Gy in 28 
fractions followed by a boost dose to the tumor bed 
according to risk factors in 81.3%. In 18.7% supraclavicular 
nodes were treated with 50Gy.The median age at first 
diagnosis was 53.3 years (range 36- 69.7). 78.1% of the 
women were postmenopausal. 81.25% of the tumors were 
pathologically classified as T1, 12.5% as T2 and 6.25% as 
